Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-010723

Chief Operating Officer gave up 3,098 shares (to pay taxes)

  • Chief Operating Officer acquired 8,952 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2024-03-31 Option exercise +8,952 60,722 D
Cittadine Andrew Chief Operating Officer 2024-03-31 Shares withheld for taxes −3,098 $0.68 $2,110 57,624 D
Derivatives
Cittadine Andrew Chief Operating Officer 2024-03-31 Option exercise · Restricted Stock Units −8,952 82,223 D
Loading xslF345X05/rdgdoc.xml…